TNF-receptor levels in preeclampsia - Results of a longitudinal study in high-risk women

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 18, Issue 5, 2005, Pages 283-287

  Schipper, Elbert Jaap I ^a   Bolte, Antoinette C ^a   Schalkwijk, Casper G ^b   Van Geijn, Herman P ^a   Dekker, Gustaaf A ^c  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Fetal growth restriction; Preeclampsia; Tumor necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR RECEPTOR 1;

ADULT; ANAMNESIS; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELIVERY; DISEASE SEVERITY; FEMALE; GESTATION PERIOD; HIGH RISK POPULATION; HUMAN; INTRAUTERINE GROWTH RETARDATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PREECLAMPSIA; PREGNANCY; PRIMIGRAVIDA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; REPRODUCTION; SECOND TRIMESTER PREGNANCY; STATISTICAL SIGNIFICANCE; THIRD TRIMESTER PREGNANCY;

ADULT; FEMALE; FETAL GROWTH RETARDATION; GESTATIONAL AGE; HUMANS; LONGITUDINAL STUDIES; PRE-ECLAMPSIA; PREGNANCY; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 30344461586     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050500246466     Document Type: Article

References (26)

1. National High Blood Pressure Education Program Working Group report on high blood pressure in pregnancy. Am J Obstet Gynecol 1990;163:1691-1712.
2. Brown MA, Hague WM, Higgins J, Lowe S, McCowan L, Oats J, Peek MJ, Rowan JA, Walters BN. The detection, investigation and management of hypertension in pregnancy: Full consensus statement. Aust N Z J Obstet Gynaecol 2000; 40:139-155.
3. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001;20:IX-XIV.
4. Roberts JM. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 1998;16:5-15.
5. Dekker GA, Robillard PY, Hulsey TC. Immune maladaptation in the etiology of preeclampsia: A review of corroborative epidemiologic studies. Obstet Gynecol Surv 1998;53:377-382.
6. Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: Current concepts. Am J Obstet Gynecol 1998; 179:1359-1375.
7. Dekker GA, Sibai BM. The immunology of preeclampsia. Semin Perinatol 1999;23:24-33.
8. Taylor RN. Review: Immunobiology of preeclampsia. Am J Reprod Immunol 1997;37:79-86.
9. Sacks G, Sargent I, Redman C. An innate view of human pregnancy. Immunol Today 1999;20:114-118.
10. Reinhard G, Noll A, Schlebusch H, Mallmann P, Ruecker AV. Shifts in the TH1/TH2 balance during human pregnancy correlate with apoptotic changes. Biochem Biophys Res Commun 1998; 245:933-938.
11. Redman CW, Sacks GP, Sargent IL. Preeclampsia: An excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180:499-506.
12. Conrad KP, Benyo DF. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol 1997;37:240-249.
13. Hamai Y, Fujii T, Yamashita T, Nishina H, Kozuma S, Mikami Y, Taketani Y. Evidence for an elevation in serum interleukin-2 and tumor necrosis factor-alpha levels before the clinical manifestations of preeclampsia. Am J Reprod Immunol 1997;38:89-93.
14. Gardosi J. Customized growth curves. Clin Obstet Gynecol 1997;40:715-722.
15. Carr DB, McDonald GB, Brateng D, Desai M, Thach CT, Easterling TR. The relationship between hemodynamics and inflammatory activation in women at risk for preeclampsia. Obstet Gynecol 2001;98:1109-1116.
16. Vince GS, Starkey PM, Austgulen R, Kwaitkowski D, Redman CW. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with preeclampsia. Br J Obstet Gynaecol 1995;102:20-25.
17. Kupferminc MJ, Peaceman AM, Aderka D, Wallach D, Socol ML. Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia. Obstet Gynecol 1996;88: 420-427.
18. Visser W, Beckmann I, Knook M, Wallenburg H. Soluble tumor necrosis factor receptor II and soluble cell adhesion molecule 1 as markers of tumor necrosis factor-alpha release in preeclampsia. Acta Obstet Gynecol Scand 2002;81:713-719.
19. Williams MA, Mahomed K, Farrand A, Woelk GB, Mudzamiri S, Madzime S, King IB, McDonald GB. Plasma tumor necrosis factor-alpha soluble receptor p55 (sTNFp55) concentrations in eclamptic, preeclamptic and normotensive pregnant Zimbabwean women. J Reprod Immunol 1998; 40:159-173.
20. Sanchez SE, Zhang C, Williams MA, Ware-Jauregui S, Larrabure G, Bazul V, Farrand A. Tumor necrosis factor-alpha soluble receptor p55 (sTNFp55) and risk of preeclampsia in Peruvian women. J Reprod Immunol 2000; 47:49-63.
21. Williams MA, Farrand A, Mittendorf R, Sorensen TK, Zingheim RW, O'Reilly GC, King IB, Zebelman AM, Luthy DA. Maternal second trimester serum tumor necrosis factor-alpha-soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia. Am J Epidemiol 1999;149:323-329.
22. Greer IA, Lyall F, Perera T, Boswell F, Macara LM. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: A mechanism for endothelial dysfunction? Obstet Gynecol 1994;84:937-940.
23. Heyl W, Handt S, Reister F, Gehlen J, Schroder W, Mittermayer C, Rath W. Elevated soluble adhesion molecules in women with pre-eclampsia. Do cytokines like tumour necrosis factor-alpha and interleukin-1beta cause endothelial activation? Eur J Obstet Gynecol Reprod Biol 1999;86:35-41.
24. Djurovic S, Clausen T, Wergeland R, Brosstad F, Bera K, Henrikson T. Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia. Br J Obstet Gynaecol 2002;109:759-764.
25. Meekins JW, McLaughlin PJ, West DC, McFadyen IR, Johnson PM. Endothelial cell activation by tumour necrosis factor-alpha (TNF-alpha) and the development of preeclampsia. Clin Exp Immunol 1994;98:110-114.
26. Conrad KP, Miles TM, Benyo DF. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol 1998;40:102-111.